トランスフェクション試薬および機器市場ー製品別（試薬、および機器）、方法別（生化学的、遺伝子発現研究、癌研究、など）、用途別、エンドユーザー別、および地域別ー世界予測2022ー2030年
SDKI Inc.は、「トランスフェクション試薬および機器市場ー世界予測2022ー2030年」新レポートを 2021年12月15日に発刊しました。この調査には、トランスフェクション試薬および機器市場の成長に必要な統計的および分析的アプローチが含まれています。レポートで提供される主要な産業の洞察は、市場の既存のシナリオに関する読者に市場の概要についてのより良いアイデアを提供します。さらに、レポートには、市場の成長に関連する現在および将来の市場動向に関する詳細な議論が含まれています。
レポートのサンプルURL
https://www.sdki.jp/sample-request-107597
レポートのサンプルURL
https://www.sdki.jp/sample-request-107597
The transfection reagent and equipment market is estimated to grow from a market value of US $ 1,034.06 million in 2022 to US $ 1,738.02 million by 2030, with a CAGR of 7.7% during the 2022-2030 forecast period. It is expected.
Details of the research report
https://www.sdki.jp/press-details/transfection-reagents-and-equipment-market/245
Transfection presents genetic substances such as DNA and RNA to eukaryotic cells. , A procedure that promotes protein production or clarification using the device of the cell itself. RNA transfection with two complementary strands is used to stop the production of some proteins by limiting the conversion procedure. Transfection procedures enable the study of gene function and expression, gene mutations, and protein function.
In addition, the biopharmacy industry has recently witnessed a significant patent cliff as some potential biopharmaceuticals are facing patent expiration. As a result, some companies are shifting their investment in the manufacture of biosimilar alternatives to unpatented biopharmaceuticals, overcoming the threat of loss of revenue. Therefore, the threat of this new patent cliff has led to the high adoption of transfection technology. This has significantly driven the growth of the transfection reagent and equipment market during the forecast period.
Transfection Reagents and Equipment Market Segment
The transfection reagent and equipment market is by product (reagents and equipment), by method (biochemical, gene expression research, cancer research, transgenic model, physical, and virus), by application (biomedical research, protein). Divided by production and therapeutic delivery), by end user (academic and laboratory, pharmaceutical and biotechnology companies), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.
Based on the product, reagents are used for transfection, including siRNA transfection kits, stem cell transfection kits, transfection optimization kits, and transfection buffers. The different methods of transfection include the use of different reagents, which has generated significant revenue in this segment. In addition, this segment is expected to gain significant market share during the forecast period. This is due to the increasing commercial adoption of these reagents.
Regional overview of the
transfection reagent and equipment market The transfection reagent and equipment market is further subdivided based on region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.
The North American region was a major revenue contributor to the transfection reagents and equipment market in 2019. This is due to the well-established genomic industry and biopharmacy in the region. The presence of a dominant company offering a wide variety of solutions to assist the different end users in the region has also contributed to the growth of the transfection reagents and equipment market in the region. Meanwhile, the Asia Pacific transfection reagents and equipment market is expected to register for rapid growth during the forecast period. Increasing numbers of biopharmacy and clinical research and development programs, increased medical research funding, and increased awareness of cytological and proteomics development are key factors driving the growth of the transfection reagent and equipment market in the region. ..
Key Players in the
Transfection Reagents and Equipment Market Key players in the transfection reagent and equipment market include Thermo Fisher Scientific Inc, PROMEGA CORPORATION, Lonza Group Ltd, Qiagen NV, Bio-Rad Laboratories, Inc, Maxcyte, Inc. , Merck KGaA, Polyplus-Transfection Sa, F.Hoffmann-LaRoche Ltd, Mirus Bio LLC and more. The study includes a detailed competitive analysis of these major companies in the transfection reagents and equipment market, company profiles, recent developments, and key market strategies.
Report sample URL
https://www.sdki.jp/sample-request-107597
SDKI Inc. Company profile
SDKI Inc.'s goal is to uncover market scenarios for different countries such as Japan, China, the United States, Canada, the United Kingdom and Germany. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. SDKI has gained trust and a customer base in more than 30 countries and is further focused on expanding its foothold in other pristine economies.
Details of the research report
https://www.sdki.jp/press-details/transfection-reagents-and-equipment-market/245
Transfection presents genetic substances such as DNA and RNA to eukaryotic cells. , A procedure that promotes protein production or clarification using the device of the cell itself. RNA transfection with two complementary strands is used to stop the production of some proteins by limiting the conversion procedure. Transfection procedures enable the study of gene function and expression, gene mutations, and protein function.
In addition, the biopharmacy industry has recently witnessed a significant patent cliff as some potential biopharmaceuticals are facing patent expiration. As a result, some companies are shifting their investment in the manufacture of biosimilar alternatives to unpatented biopharmaceuticals, overcoming the threat of loss of revenue. Therefore, the threat of this new patent cliff has led to the high adoption of transfection technology. This has significantly driven the growth of the transfection reagent and equipment market during the forecast period.
Transfection Reagents and Equipment Market Segment
The transfection reagent and equipment market is by product (reagents and equipment), by method (biochemical, gene expression research, cancer research, transgenic model, physical, and virus), by application (biomedical research, protein). Divided by production and therapeutic delivery), by end user (academic and laboratory, pharmaceutical and biotechnology companies), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.
Based on the product, reagents are used for transfection, including siRNA transfection kits, stem cell transfection kits, transfection optimization kits, and transfection buffers. The different methods of transfection include the use of different reagents, which has generated significant revenue in this segment. In addition, this segment is expected to gain significant market share during the forecast period. This is due to the increasing commercial adoption of these reagents.
Regional overview of the
transfection reagent and equipment market The transfection reagent and equipment market is further subdivided based on region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.
The North American region was a major revenue contributor to the transfection reagents and equipment market in 2019. This is due to the well-established genomic industry and biopharmacy in the region. The presence of a dominant company offering a wide variety of solutions to assist the different end users in the region has also contributed to the growth of the transfection reagents and equipment market in the region. Meanwhile, the Asia Pacific transfection reagents and equipment market is expected to register for rapid growth during the forecast period. Increasing numbers of biopharmacy and clinical research and development programs, increased medical research funding, and increased awareness of cytological and proteomics development are key factors driving the growth of the transfection reagent and equipment market in the region. ..
Key Players in the
Transfection Reagents and Equipment Market Key players in the transfection reagent and equipment market include Thermo Fisher Scientific Inc, PROMEGA CORPORATION, Lonza Group Ltd, Qiagen NV, Bio-Rad Laboratories, Inc, Maxcyte, Inc. , Merck KGaA, Polyplus-Transfection Sa, F.Hoffmann-LaRoche Ltd, Mirus Bio LLC and more. The study includes a detailed competitive analysis of these major companies in the transfection reagents and equipment market, company profiles, recent developments, and key market strategies.
Report sample URL
https://www.sdki.jp/sample-request-107597
SDKI Inc. Company profile
SDKI Inc.'s goal is to uncover market scenarios for different countries such as Japan, China, the United States, Canada, the United Kingdom and Germany. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. SDKI has gained trust and a customer base in more than 30 countries and is further focused on expanding its foothold in other pristine economies.
このプレスリリースには、メディア関係者向けの情報があります
メディアユーザーログイン既に登録済みの方はこちら
メディアユーザー登録を行うと、企業担当者の連絡先や、イベント・記者会見の情報など様々な特記情報を閲覧できます。※内容はプレスリリースにより異なります。
すべての画像
